We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Line of Culture Dishes Simplifies Stem Cell Research

By LabMedica International staff writers
Posted on 18 Oct 2010
A new line of energy-treated polystyrene microplates for animal component-free growth of stem cells and other fastidious cells is now available for cell biologists and other life scientists.

Culture plates with the newly patented "Nunclon Vita Surface” have been added to the rapidly expanding catalog of cell growth products at Thermo Fisher Scientific Inc. More...
(Milford, MA, USA).

The surface of Nunclon Vita plates has been activated so that it enables direct attachment, colony formation, and growth of human embryonic stem cells (ESC) and induced pluripotent stem cells (IPS), without the need for feeder cells or matrix coatings. In media supplemented with a Rho-associated kinase (ROCK) inhibitor, human ESCs can be cultured on Nunclon Vita plates for at least 10 passages without any loss of pluripotency, or karyotype changes. One-hour treatment with 10 nanomolar Y-27632 blocks apoptosis of dissociated cultured human embryonic stem cells, increasing cloning efficiency by 25% and sustaining survival up to 30 passages. Y-27632 is a potent, ATP-competitive inhibitor of Rho-associated protein kinases including p160 ROCK and ROCK-II.

Use of Nunclon Vita plates is not restricted to stem cells. For example, human embryonic kidney cells (HEK) can be cultured with no coating with improved attachment and growth in comparison to standard tissue culture treated culture ware. Addition of the ROCK inhibitor Y-27632 to the media enhances HEK293 attachment and growth on the Nunclon Vita Surface.

By eliminating matrix coatings and feeder cells, the Nunclon Vita surface reduces culture variability and is less labor-intensive than cell lines that require matrix coatings or feeder cells.

Related Links:
Thermo Fisher Scientific Inc.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Repetitive Pipette
VWR® Stepper Pro
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.